Scynexis (SCYX) Assets Average (2014 - 2026)
Scynexis' (SCYX) quarterly Assets Average came in at $68.3 million in Q1 2026, down 13.82% YoY from $79.3 million in Q1 2025, and up 24.12% on a QoQ basis from $55.0 million in Q4 2025.
Scynexis (SCYX) Assets Average (2014 - 2026) Analysis & Trends
Scynexis (SCYX) has 13 years of Assets Average data on file, last reported at $68.3 million in Q1 2026.
- Quarterly Assets Average fell 13.82% year-over-year to $68.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.3 million (down 13.82% YoY) and the FY2025 annual result came in at $74.8 million, down 31.67% from the prior year.
- Assets Average advanced to $68.3 million in Q1 2026, from $55.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $151.7 million in Q3 2023 to a low of $55.0 million in Q4 2025.
- A 5-year average of $100.2 million and a median of $103.4 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2024 — Assets Average surged 56.01% — and 2025, when it slumped 45.97%.
- Tracing SCYX's Assets Average over 5 years: stood at $100.1 million in 2022, then surged by 38.41% to $138.5 million in 2023, then sank by 31.51% to $94.8 million in 2024, then sank by 41.96% to $55.0 million in 2025, then rose by 24.12% to $68.3 million in 2026.
- The last three Assets Average figures came in at $68.3 million (Q1 2026), $55.0 million (Q4 2025), and $55.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | 76.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 76.30 Mn |
| Mar 31, 2026 | 68.33 Mn |
| Dec 31, 2025 | 55.05 Mn |
| Sep 30, 2025 | 55.88 Mn |
| Jun 30, 2025 | 64.30 Mn |
| Mar 31, 2025 | 79.28 Mn |
| Dec 31, 2024 | 94.84 Mn |
| Sep 30, 2024 | 103.42 Mn |
| Jun 30, 2024 | 113.03 Mn |
| Mar 31, 2024 | 123.33 Mn |
| Dec 31, 2023 | 138.48 Mn |
| Sep 30, 2023 | 151.70 Mn |
| Jun 30, 2023 | 112.58 Mn |
| Mar 31, 2023 | 79.05 Mn |
| Dec 31, 2022 | 100.05 Mn |
| Sep 30, 2022 | 123.95 Mn |
| Jun 30, 2022 | 123.59 Mn |
| Mar 31, 2022 | 115.70 Mn |
| Dec 31, 2021 | 114.86 Mn |
| Sep 30, 2021 | 115.51 Mn |